Speaker illustration

Doctor Maurizio Landolina

Maggiore Hospital of Crema, Crema (Italy)

Member of:

European Society of Cardiology
European Heart Rythm Association

End-of-life decisions in ICD carriers - When should ICD therapy be re-considered?

Event: EHRA 2019

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: ICD management in real life

Thumbnail

Ventricular pacing percentage and atrial fibrillation risk in dual chamber cardiac implantable devices.

Event: ESC Congress 2018

Topic: Pacemaker Therapy

Session: Novel aspects of anti bradycardia pacing

Thumbnail

Use of anti-arrhythmic drug therapy following cryoballoon ablation of paroxysmal atrial fibrillation does not lead to improved clinical outcome. Data from a multicenter observational project.

Event: ESC Congress 2018

Topic: Rhythm Control, Catheter Ablation

Session: Atrial fibrillation ablation

Thumbnail

Use of anti-arrhythmic drug therapy in patients treated with Cryoballoon pulmonary vein isolation for paroxysmal atrial fibrillation: data from a multicenter observational project

Event: EHRA 2018

Topic: Catheter Ablation of Arrhythmias

Session: Atrial fibrillation ablation - Cryoballoon

Thumbnail

In CRT-D patients reverse remodeling and occurrence of VT/VF episodes, but not defibrillator therapies, are determinants of death or HF hospitalization risk.

Event: ESC CONGRESS 2017

Topic: Resynchronisation therapy

Session: Cardiac resynchronisation therapy

Thumbnail

Procedural data, peri-procedural complications and long term outcomes of cryoballoon ablation of paroxysmal atrial fibrillation: the influence of center expertise (high volume vs low volume)

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: Atrial fibrillation ablation

Thumbnail

Left ventricular reverse remodeling by cardiac resynchronization is associated with lower risk of ventricular tachyarrhythmias

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Results (Resynchronization therapy)

Session: Cardiac resynchronisation therapy

Thumbnail

The economic impact of longevity of implantable cardioverter-defibrillator for cardiac resynchronization therapy from a healthcare service perspective

Event: ESC CONGRESS 2016

Topic: Automatic implantable cardioverter / defibrillator

Session: Ventricular arrhythmia, ICD and remote monitoring

Thumbnail

Impact of CRT-D implantation on clinical outcomes and healthcare resource utilization: an Italian cohort study

Event: ESC CONGRESS 2016

Topic: Heart failure, other

Session: Resynchronisation and defibrillation devices in systolic heart failure

Thumbnail

This platform is supported by

logo Novo Nordisk